It’s a kind of control that no one has ever tried before in patients,” Tune’s chief scientific officer said Monday.

The shooting happened Saturday afternoon at Magnolia Pointe Apartments on Danube Lane in northeast Durham. The friend who ...

Duke Graduate and Professional Student Government heard a presentation from University administrators addressing Duke's ...

The Chronicle compiled a list of opportunities to celebrate King’s life and continue his tradition of service at Duke and in ...

As shared by the Boston Herald's Zack Cox, the ticket map at the Eagles' Conte Forum for Saturday is staggering. The current ...

Scientists at Duke University's Human Vaccine Institute have made a significant advance in the quest for an HIV vaccine.

DURHAM, N.C. (WTVD) -- Scientists at Duke University's Human Vaccine Institute have made a significant advance in the quest for an HIV vaccine, successfully developing a vaccine candidate that ...

Steve Wiseman has covered Duke athletics since 2010 for the Durham Herald-Sun and Raleigh ... s Carolina Panthers and New Orleans Saints, University of South Carolina athletics and the S.C ...

Tune Therapeutics, an epigenome-editing company with origins at Duke University, has raised over $175 million in financing to advance a potential treatment for chronic hepatitis B and other diseases.

Duke played with coach Jon Scheyer back in Durham battling the flu but delivered a stellar performance nevertheless. Behind ...

A new health care firm led by executives with ties to the Triangle has acquired a Durham company. Highlander Health, an Dallas-based entity formed last year to advance evidence ge ...